Challenges and Opportunities for Biotech Quality by Design

Due to the complex nature of protein therapeutics, there are unique challenges and opportunities to implement a Quality by Design (QbD) approach for the biotechnology-derived products. This chapter describes bioprocessing schemes for both liquid and lyophilized drug products. The International Conference on Harmonization (ICH) guidance documents are discussed in the context of bioprocessing to provide examples of the systematic QbD approach. Additionally, this chapter discusses the role of process analytical technologies (PAT) and design of experiments (DoEs) as complementary approaches in upstream and downstream process could serve to support the overall development and manufacture of a quality product. The ultimate goal of QbD is a well-understood process and high-quality product with a commitment to continuous improvement.

[1]  A S Rathore,et al.  Process analytical technology (PAT) for biopharmaceutical products: Part I. concepts and applications , 2010, Biotechnology and bioengineering.

[2]  Diego Matteuzzi,et al.  Assessment of In‐Line Near‐Infrared Spectroscopy for Continuous Monitoring of Fermentation Processes , 2003, Biotechnology progress.

[3]  S. Arnold,et al.  Use of at‐line and in‐situ near‐infrared spectroscopy to monitor biomass in an industrial fed‐batch Escherichia coli process , 2002, Biotechnology and bioengineering.

[4]  T Kobayashi,et al.  Growth characteristics in fed‐batch culture of hybridoma cells with control of glucose and glutamine concentrations , 1994, Biotechnology and bioengineering.

[5]  M. Khan,et al.  Optimization of a self-nanoemulsified tablet dosage form of Ubiquinone using response surface methodology: effect of formulation ingredients. , 2002, International journal of pharmaceutics.

[6]  J Z Knapp,et al.  Automated particulate inspection systems: strategies and implications. , 1990, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.

[7]  R. Powers,et al.  Simple and rapid quantitative high-performance liquid chromatographic analysis of plasma amino acids. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[8]  Anurag S. Rathore,et al.  Filter Clogging Issues in Sterile Filtration , 2008 .

[9]  Kurt Brorson,et al.  Disposable bioprocessing: the future has arrived. , 2009, Biotechnology and bioengineering.

[10]  Xiaolin Tang,et al.  Design of Freeze-Drying Processes for Pharmaceuticals: Practical Advice , 2004, Pharmaceutical Research.

[11]  Ashraf Amanullah,et al.  Twenty‐four well plate miniature bioreactor system as a scale‐down model for cell culture process development , 2009, Biotechnology and bioengineering.

[12]  M. Khan,et al.  Quality by design: understanding the formulation variables of a cyclosporine A self-nanoemulsified drug delivery systems by Box-Behnken design and desirability function. , 2007, International journal of pharmaceutics.

[13]  Michael J. Pikal,et al.  Evaluation of manometric temperature measurement, a process analytical technology tool for freeze-drying: Part II measurement of dry-layer resistance , 2008, AAPS PharmSciTech.

[14]  Michael J. Pikal,et al.  Evaluation of manometric temperature measurement (MTM), a process analytical technology tool in freeze drying, part III: Heat and mass transfer measurement , 2008, AAPS PharmSciTech.

[15]  Anurag S Rathore,et al.  Roadmap for implementation of quality by design (QbD) for biotechnology products. , 2009, Trends in biotechnology.

[16]  Lilli Møller Andersen,et al.  Quality Risk Management , 2021, Handbook of Pharmaceutical Manufacturing Formulations, Second Edition.

[17]  Rani J Qasem.  The effect of microwave thermal denaturation on release properties of bovine serum albumin and gluten matrices , 2006, AAPS PharmSciTech.

[18]  J. Carpenter,et al.  Infrared microscopy for in situ measurement of protein secondary structure during freezing and freeze-drying. , 2007, Journal of pharmaceutical sciences.

[19]  A Dual Controlled Gastrointestinal Therapeutic System of Salmon Calcitonin. II. Screening of Process and Formulation Variables , 2004 .

[20]  Sarfaraz K. Niazi,et al.  Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances , 2016, Handbook of Pharmaceutical Manufacturing Formulations, Second Edition.

[21]  A. Rathore,et al.  Quality by design for biopharmaceuticals , 2009, Nature Biotechnology.

[22]  Brian McNeil,et al.  Multiplexing fibre optic near infrared (NIR) spectroscopy as an emerging technology to monitor industrial bioprocesses. , 2007, Analytica chimica acta.

[23]  F. García-Ochoa,et al.  Bioreactor scale-up and oxygen transfer rate in microbial processes: an overview. , 2009, Biotechnology advances.

[24]  Xiaolin Tang,et al.  Evaluation of manometric temperature measurement, a process analytical technology tool for freeze-drying: Part I, product temperature measurement , 2006, AAPS PharmSciTech.

[25]  M. Pikal,et al.  Process control in freeze drying: determination of the end point of sublimation drying by an electronic moisture sensor. , 1989, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.